Clinical Trial Update: Alirocumab and Plaque Burden In Familial Hypercholesterolaemia [Phase 4]

View source ↗

Summary

Phase 4 trial update on alirocumab and plaque burden in familial hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Fundación Hipercolesterolemia Familiar | Conditions: Familial Hypercholesterolemia | Phase 4 | Status: COMPLETED